Association Study of Glutathione S-transferases Gene Polymorphisms (GSTM1 and GSTT1) with Ulcerative Colitis and Crohn's Disease in the South of Iran

Moini, Maryam; Saadat, Mostafa; Saadat, Hooshang; Esmailnejad, Atefeh; Safarpour, Alireza

Association Study of Glutathione S-transferases Gene Polymorphisms (GSTM1 and GSTT1) with Ulcerative Colitis and Crohn's Disease in the South of Iran

Document Type : Original Article

Authors

¹ Department of Internal Medicine, Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

² Department of Biology, College of Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran

³ Department of Pathobiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran

Abstract

Background: Inflammatory bowel diseases (IBDs), including ulcerative colitis (UC) and Crohn's disease (CD), are chronic inflammatory disorders of the gastrointestinal tract. A combination of environmental factors and interactions with a genetic predisposition are suggested to play an important role in the etiology and pathogenesis of the IBD. Glutathione S-transferases (GSTs) are multifunctional enzymes involved in the cellular oxidative stress handling. Possible associations between GSTs gene polymorphisms and susceptibility to UC and CD have been reported in different population. The relationship between GSTM1 and GSTT1 deletion polymorphisms and susceptibility to UC and CD were investigated in the Iranian population. Materials and Methods: The study was performed in 106 IBD patients and 243 age- and sex-matched healthy Iranian controls consulting the IBD registry center of the Motahari Clinic, Shiraz University of Medical Sciences, Shiraz, Iran, between 2011 and 2013. GSTM1 and GSTT1 genotyping were performed using multiplex polymerase chain reaction and differences in the distribution of gene polymorphisms were analyzed statistically between the studied groups. Results: Statistically significant higher frequency of GSTM1 null genotype was observed in IBD patients (P = 0.01) and in the subgroup of patients with UC (P = 0.04) compared to healthy controls, whereas this was not true for CD patients. No significant association was found between GSTT1 gene polymorphism and UC or CD. Conclusions: Absence of GSTT1 functional gene does not play an important role in the pathophysiology and development of IBD, UC, and CD in Iranian population whereas GSTM1 null genotype could be considered as a possible genetic predisposing factor for more susceptibility to IBD and UC.

Keywords

References

1.	Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011;474:307-17.
2.	Ye X, Jiang Y, Wang H, Chen L, Yuan S, Xia B. Genetic polymorphisms of glutathione S-transferases are associated with ulcerative colitis in central China. Cell Biochem Biophys 2011;60:323-8.
3.	Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003;124:521-36.
4.	Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2010;6:339-46.
5.	Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene 2006;314:1461-3.
6.	Kim SW, Kim ES, Moon CM, Park JJ, Kim TI, Kim WH, et al. Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease. Gut 2011;60:1527-36.
7.	Moon CM, Shin DJ, Son NH, Shin ES, Hong SP, Kim TI, et al. Genetic variants in the IL12B gene are associated with inflammatory bowel diseases in the Korean population. J Gastroenterol Hepatol 2013;28:1588-94.
8.	Bouzid D, Kammoun A, Amouri A, Mahfoudh N, Haddouk S, Tahri N, et al. Inflammatory bowel disease: Susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping. Genet Test Mol Biomarkers 2012;16:482-7.
9.	Tahara T, Shibata T, Nakamura M, Okubo M, Yamashita H, Yoshioka D, et al. Association between polymorphisms in the XRCC1 and GST genes, and CpG island methylation status in colonic mucosa in ulcerative colitis. Virchows Arch 2011;458:205-11.
10.	Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996;41:2078-86.
11.	Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: An epiphenomenon or the cause? Dig Dis Sci 2007;52:2015-21.
12.	de Jong DJ, van der Logt EM, van Schaik A, Roelofs HM, Peters WH, Naber TH. Genetic polymorphisms in biotransformation enzymes in Crohn's disease: Association with microsomal epoxide hydrolase. Gut 2003;52:547-51.
13.	Duncan H, Swan C, Green J, Jones P, Brannigan K, Alldersea J, et al. Susceptibility to ulcerative colitis and Crohn's disease: Interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes. Clin Chim Acta 1995;240:53-61.
14.	Buyukgoze O, Osmanoglu N, Arslan S, Sen A. Association of the CYP1A12A, GSTT1 null, GSTM1 null, mEPHX3, and XRCC1-399 genetic polymorphisms with ulcerative colitis. Int J Colorectal Dis 2013;28:593-5.
15.	Garcia-Closas M, Kelsey KT, Wiencke JK, Xu X, Wain JC, Christiani DC. A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States). Cancer Causes Control 1997;8:544-53.
16.	Sergentanis TN, Economopoulos KP, Choussein S, Vlahos NF. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and cervical cancer risk: A meta-analysis. Mol Biol Rep 2012;39:6647-54.
17.	Wan H, Zhou Y, Yang P, Chen B, Jia G, Wu X. Genetic polymorphism of glutathione S-transferase T1 and the risk of colorectal cancer: A meta-analysis. Cancer Epidemiol 2010;34:66-72.
18.	Eaton DL, Bammler TK. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 1999;49:156-64.
19.	Khan MI, Micheal S, Akhtar F, Ahmed W, Ijaz B, Ahmed A, et al. The association of glutathione S-transferase GSTT1 and GSTM1 gene polymorphism with pseudoexfoliative glaucoma in a Pakistani population. Mol Vis 2010;16:2146-52.
20.	Stocco G, Martelossi S, Barabino A, Decorti G, Bartoli F, Montico M, et al. Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease. Inflamm Bowel Dis 2007;13:57-64.
21.	Economopoulos KP, Sergentanis TN. GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: A comprehensive meta-analysis. Eur J Cancer 2010;46:1617-31.
22.	Karban A, Krivoy N, Elkin H, Adler L, Chowers Y, Eliakim R, et al. Non-Jewish Israeli IBD patients have significantly higher glutathione S-transferase GSTT1-null frequency. Dig Dis Sci 2011;56:2081-7.
23.	Mittal RD, Manchanda PK, Bid HK, Ghoshal UC. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: Study from Northern India. J Gastroenterol Hepatol 2007;22:920-4.
24.	Kruidenier L, Verspaget HW. Review article: Oxidative stress as a pathogenic factor in inflammatory bowel disease – Radicals or ridiculous? Aliment Pharmacol Ther 2002;16:1997-2015.
25.	Zhu H, Li YR. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: Updated experimental and clinical evidence. Exp Biol Med (Maywood) 2012;237:474-80.
26.	Ghobadloo SM, Yaghmaei B, Bakayev V, Goudarzi H, Noorinayer B, Rad FH, et al. GSTP1, GSTM1, and GSTT1 genetic polymorphisms in patients with cryptogenic liver cirrhosis. J Gastrointest Surg 2004;8:423-7.
27.	Stücker I, Hirvonen A, de Waziers I, Cabelguenne A, Mitrunen K, Cénée S, et al. Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis 2002;23:1475-81.
28.	Zupa A, Sgambato A, Bianchino G, Improta G, Grieco V, LA Torre G, et al. GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: A case-control study. Anticancer Res 2009;29:1709-14.
29.	Curran JE, Weinstein SR, Griffiths LR. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility. Cancer Lett 2000;153:113-20.
30.	Zeng FF, Liu SY, Wei W, Yao SP, Zhu S, Li KS, et al. Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: A meta-analysis. Clin Exp Med 2010;10:59-68.
31.	Ernst A, Andersen V, Østergaard M, Jacobsen BA, Dagiliene E, Pedersen IS, et al. Genetic variants of glutathione S-transferases mu, theta, and pi display no susceptibility to inflammatory bowel disease in the Danish population. Scand J Gastroenterol 2010;45:1068-75.

Advanced Biomedical Research